{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:21:31Z","timestamp":1787775691065,"version":"build-2784847793"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Natalizumab is a disease-modifying drug that has proved greatly effective and well-tolerated in highly-active Multiple Sclerosis (MS). However, it may increase the risk for opportunistic infections, such as viral ones. We describe a 37-year-old woman treated with Natalizumab for Relapsing-Remitting Multiple Sclerosis (RR-MS) who presented to our clinic with malaise, arthromyalgias, rash, and fever. She later developed diarrhea and severe abdominal pain. A diagnosis of parvovirus B19 (B19V) infection and acute acalculous cholecystitis (AAC) was eventually made. To our knowledge, this is the first reported case of AAC possibly related to Natalizumab therapy and B19V infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0028-3886.314544","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T01:30:50Z","timestamp":1619400650000},"page":"495-496","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Acute Acalculous Cholecystitis in a Multiple Sclerosis Patient Treated with Natalizumab"],"prefix":"10.4103","volume":"69","author":[{"given":"\u00c1lvaro","family":"Lambea-Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Fumanal-Idocin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Sebasti\u00e1n-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Salda\u00f1a-Inda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patxi","family":"Huici-Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Alarcia-Jos\u00e9-Ram\u00f3n-Ram\u00f3n Ara-Callizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-57-20240907","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cgh.2009.08.034","article-title":"Acute acalculous cholecystitis: A review","volume":"8","author":"Huffman","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R2-57-20240907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756286419836571","article-title":"Risks and risk management in modern multiple sclerosis immunotherapeutic treatment","volume":"12","author":"Klotz","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"R4-57-20240907","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.gtc.2010.02.012","article-title":"Acute acalculous cholecystitis","volume":"39","author":"Barie","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"R5-57-20240907","doi-asserted-by":"crossref","first-page":"e1548","DOI":"10.1212\/WNL.0000000000005422","article-title":"Acute acalculous cholecystitis: A new safety risk for patients with MS treated with alemtuzumab","volume":"90","author":"Croteau","year":"2018","journal-title":"Neurology"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.314544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:39:14Z","timestamp":1787773154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.314544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/0028-3886.314544","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}